Abstract
The kinetics of appearance of five humoral antibody responses (micro-neutralization assay [NT], complement fixation [CF], enzyme-linked immunosorbent assay [ELISA], radioimmunoassay [RIA], antibody-dependent cell-mediated cytotoxicity [ADCC]), were compared during labial infection of BALB/c mice with herpes simplex virus type 1 strain Patton. The ELISA/RIA antibody responses were present in most mice by day 5 after infection, at the beginning of the herpetic lip lesions; antibody effective in ADCC showed identical early kinetics. In contrast, NT/CF antibodies were not detected in most mice until day 10, at the time of resolution of the herpetic lip lesions. The humoral immune responses persisted for at least 6 months after infection. The NT and CF responses were closely correlated in time of appearance and titers (r = 0.9), as were the ELISA and RIA responses (r = 0.99). However, there was little correlation between NT/CF and ELISA/RIA responses (r = 0.02). The kinetics of the delayed type hypersensitivity response showed similar kinetics of appearance to the ELISA/RIA/ADCC humoral responses, and peaked similarly, but waned gradually over 2 months. The importance of antibody in protection against labial herpes simplex virus type 1 infection was demonstrated by the ability of passively transferred convalescent serum (that produced a minimum NT titer of 10 in recipient mice) to protect against development of herpetic lesions and death.
MeSH Terms
Animals
Antibodies, Viral/biosynthesis
Complement Fixation Tests
Enzyme-Linked Immunosorbent Assay
Herpes Simplex/microbiology
Hypersensitivity, Delayed/immunology
Immunization, Passive
Kinetics
Lip Diseases/etiology,microbiology
Lymphocytes/immunology
Male
Mice
Mice, Inbred BALB C
Neutralization Tests
Radioimmunoassay
Chemicals
Antibodies, Viral
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Morahan P S
Thomson T A
Kohl S
Murray B K
References (25)
25 references, click to expand
-
Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.
J Infect Dis. 1973 Jun;127(6):632-8
PMID: 4350518
-
Cellular immunity to herpes simplex virus mediated by interferon.
J Exp Med. 1974 Sep 1;140(3):764-78
PMID: 4369835
-
Maintenance of latent herpetic infection: an apparent role for anti-viral IgG.
J Immunol. 1974 Dec;113(6):1685-93
PMID: 4372269
-
Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.
Science. 1975 May 30;188(4191):938-40
PMID: 166432
-
Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.
Infect Immun. 1975 Jul;12(1):166-72
PMID: 166926
-
Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.
Lancet. 1975 Jul 12;2(7924):60-2
PMID: 49654
-
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
J Immunol. 1976 Jan;116(1):35-40
PMID: 173758
-
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections.
Cell Immunol. 1976 Mar 1;22(1):182-6
PMID: 179716
-
Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus.
Nature. 1976 Dec 9;264(5586):554-6
PMID: 1004594
-
The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
J Immunol. 1977 Feb;118(2):567-73
PMID: 65428
-
Pathogenesis of latent herpes simplex virus infection of the trigeminal ganglion in guinea pigs: effects of age, passive immunization, and hydrocortisone.
Infect Immun. 1977 Apr;16(1):69-74
PMID: 301508
-
Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.
Infect Immun. 1977 Jun;16(3):955-60
PMID: 197013
-
Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2.
J Immunol. 1977 Dec;119(6):2030-6
PMID: 72115
-
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.
Infect Immun. 1978 Aug;21(2):489-95
PMID: 689732
-
Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.
Infect Immun. 1979 Feb;23(2):305-11
PMID: 217828
-
Route of infection, systemic host resistance, and integrity of ganglionic axons influence acute and latent herpes simplex virus infection of the superior cervical ganglion.
Infect Immun. 1979 Feb;23(2):373-83
PMID: 422245
-
Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
J Immunol. 1979 Jul;123(1):25-30
PMID: 448149
-
Immune control of herpesvirus latency.
Can J Microbiol. 1979 Mar;25(3):267-74
PMID: 222416
-
Effect of pyran on latency after herpes simplex virus infections.
Antimicrob Agents Chemother. 1979 Apr;15(4):547-53
PMID: 464586
-
Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.
J Infect Dis. 1979 Oct;140(4):534-40
PMID: 229174
-
The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.
J Exp Med. 1979 Dec 1;150(6):1549-54
PMID: 229190
-
Acylovir in oral and ganglionic herpes simplex virus infections.
J Infect Dis. 1979 Nov;140(5):802-6
PMID: 316819
-
Serum antibodies to herpes simplex virus type 1 during active oral herpes infection.
Infect Immun. 1980 Jan;27(1):113-7
PMID: 6244224
-
Topical therapeutic efficacy of 9-(2-hydroxyethoxymethyl)guanine and 5-iodo-5'-amino-2',5'-dideoxyuridine on oral infection with herpes simplex virus in mice.
J Infect Dis. 1980 May;141(5):575-9
PMID: 6966305
-
MHC matching shows that at least two T-cell subsets determine resistance to HSV.
Nature. 1979 Jan 4;277(5691):66-8
PMID: 233263